BriaCell Therapeutics Corp. Announces Closing of US$27.2 Million Private Placement

NEXT STORY
Roche obtains CE mark for the SARS-CoV-2 Antigen Self Test Nasal allowing for rapid self testing of COVID-19 at home
PREV STORY
EBS Investor Reminder: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Against Emergent BioSolutions Inc.
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Idera Pharmaceuticals Presents the Novel Mechanism of Action of its Third Generation Antisense Technology

CAMBRIDGE, Mass. and EXTON, Pa., Aug. 24, 2016 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. ...

author_avatar
NASDAQ Market News

GeoVax Provides Vaccine Development Update

ATLANTA, GA, March 28, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a ...

author_avatar
NASDAQ Market News

Project HOPE with Support from Eli Lilly and Company Makes Strides against Diabetes and Hypertension in India

MILLWOOD, VA., April 6, 2016 (GLOBE NEWSWIRE) -- Project HOPE, the global health organization, ...

author_avatar
NASDAQ Market News